MicroRNA regulation of F-box proteins and its role in cancer. (February 2016)
- Record Type:
- Journal Article
- Title:
- MicroRNA regulation of F-box proteins and its role in cancer. (February 2016)
- Main Title:
- MicroRNA regulation of F-box proteins and its role in cancer
- Authors:
- Wu, Zhao-Hui
Pfeffer, Lawrence M. - Abstract:
- Abstract: MicroRNAs (miRNAs) are small endogenous non-coding RNAs, which play critical roles in cancer development by suppressing gene expression at the post-transcriptional level. In general, oncogenic miRNAs are upregulated in cancer, while miRNAs that act as tumor suppressors are downregulated, leading to decreased expression of tumor suppressors and upregulated oncogene expression, respectively. F-box proteins function as the substrate-recognition components of the SKP1-CUL1-F-box (SCF)-ubiquitin ligase complex for the degradation of their protein targets by the ubiquitin-proteasome system. Therefore F-box proteins and miRNAs both negatively regulate target gene expression post-transcriptionally. Since each miRNA is capable of fine-tuning the expression of multiple target genes, multiple F-box proteins may be suppressed by the same miRNA. Meanwhile, one F-box proteins could be regulated by several miRNAs in different cancer types. In this review, we will focus on miRNA-mediated downregulation of various F-box proteins, the resulting stabilization of F-box protein substrates and the impact of these processes on human malignancies. We provide insight into how the miRNA: F-box protein axis may regulate cancer progression and metastasis. We also consider the broader role of F-box proteins in the regulation of pathways that are independent of the ubiquitin ligase complex and how that impacts on oncogenesis. The area of miRNAs and the F-box proteins that they regulate inAbstract: MicroRNAs (miRNAs) are small endogenous non-coding RNAs, which play critical roles in cancer development by suppressing gene expression at the post-transcriptional level. In general, oncogenic miRNAs are upregulated in cancer, while miRNAs that act as tumor suppressors are downregulated, leading to decreased expression of tumor suppressors and upregulated oncogene expression, respectively. F-box proteins function as the substrate-recognition components of the SKP1-CUL1-F-box (SCF)-ubiquitin ligase complex for the degradation of their protein targets by the ubiquitin-proteasome system. Therefore F-box proteins and miRNAs both negatively regulate target gene expression post-transcriptionally. Since each miRNA is capable of fine-tuning the expression of multiple target genes, multiple F-box proteins may be suppressed by the same miRNA. Meanwhile, one F-box proteins could be regulated by several miRNAs in different cancer types. In this review, we will focus on miRNA-mediated downregulation of various F-box proteins, the resulting stabilization of F-box protein substrates and the impact of these processes on human malignancies. We provide insight into how the miRNA: F-box protein axis may regulate cancer progression and metastasis. We also consider the broader role of F-box proteins in the regulation of pathways that are independent of the ubiquitin ligase complex and how that impacts on oncogenesis. The area of miRNAs and the F-box proteins that they regulate in cancer is an emerging field and will inform new strategies in cancer treatment. … (more)
- Is Part Of:
- Seminars in cancer biology. Volume 36(2016)
- Journal:
- Seminars in cancer biology
- Issue:
- Volume 36(2016)
- Issue Display:
- Volume 36, Issue 2016 (2016)
- Year:
- 2016
- Volume:
- 36
- Issue:
- 2016
- Issue Sort Value:
- 2016-0036-2016-0000
- Page Start:
- 80
- Page End:
- 87
- Publication Date:
- 2016-02
- Subjects:
- microRNA -- F-box protein -- Cancer
Skp1 S-phase kinase-associated protein 1 -- SCF Skp1-cullin1-F-box protein -- Rbx1 RING-box protein 1 -- β-TrCP1 β-transducin repeat-containing protein1 -- FBXL F-box and leucine-rich repeat proteins -- FBXL F-box and leucine-rich repeat proteins -- RBL2 retinoblastoma-like protein 2 -- IκBα inhibitor of nuclear factor κB -- DGCR8 DiGeorge syndrome critical region 8 -- RISC RNA-induced silencing complex -- T-ALL T cell acute lymphoblastic leukemia -- MRE miRNA recognition element -- 3′-UTR 3′ untranslated region -- BCL6 B cell lymphoma 6 -- Cdt2 Cdc10-dependent transcript 2 -- SETD8 SET domain-containing lysine methyltransferase 8 -- NSCLC non-small cell lung carcinoma -- CN-AML cytogenetically normal acute myeloid leukemia
Cancer -- Periodicals
Neoplasms -- Periodicals
Review Literature
Cancer -- Périodiques
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/1044579X ↗
http://www.clinicalkey.com/dura/browse/journalIssue/1044579X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/1044579X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.semcancer.2015.09.016 ↗
- Languages:
- English
- ISSNs:
- 1044-579X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8239.448340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 1417.xml